Gene · 84447
Papers1,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Casting Light on the Janus-Faced HMG-CoA Reductase Degradation Protein 1: A Comprehensive Review of Its Dualistic Impact on Apoptosis in Various Diseases. | Mol Neurobiol | 2024 | 38356096 | PubTator, text mining | PubMed |
| Direct observation of autoubiquitination for an integral membrane ubiquitin ligase in ERAD. | Nat Commun | 2024 | 38351109 | PubTator, text mining | PubMed |
| Genome-wide screen identifies new set of genes for improved heterologous laccase expression in Saccharomyces cerevisiae. | Microb Cell Fact | 2024 | 38287338 | PubTator, text mining | PubMed |
| Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. | Noncoding RNA Res | 2024 | 38282696 | PubTator, text mining | PubMed |
| Substrate recognition mechanism of the endoplasmic reticulum-associated ubiquitin ligase Doa10. | bioRxiv | 2024 | 38260251 | PubTator, text mining | PubMed |
| Proteomic screens of SEL1L-HRD1 ER-associated degradation substrates reveal its role in glycosylphosphatidylinositol-anchored protein biogenesis. | Nat Commun | 2024 | 38253565 | PubTator, text mining | PubMed |
| Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy. | Cells | 2024 | 38247849 | PubTator, text mining | PubMed |
| Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration. | Cells | 2024 | 38247815 | PubTator, text mining | PubMed |
| The Multifaceted Roles of NRF2 in Cancer: Friend or Foe? | Antioxidants (Basel) | 2024 | 38247494 | PubTator, text mining | PubMed |
| Unravelling cell type-specific responses to Parkinson's Disease at single cell resolution. | Mol Neurodegener | 2024 | 38245794 | PubTator, text mining | PubMed |
| Sox9 regulates alternative splicing and pancreatic beta cell function. | Nat Commun | 2024 | 38238288 | PubTator, text mining | PubMed |
| New mode of action of curcumin on prostate cancer cells: Modulation of endoplasmic reticulum-associated degradation mechanism and estrogenic signaling. | J Biochem Mol Toxicol | 2024 | 38229314 | PubTator, text mining | PubMed |
| Hypomorphic human SEL1L and HRD1 variants uncouple multilayered ER-associated degradation machinery. | J Clin Invest | 2024 | 38226624 | PubTator, text mining | PubMed |
| PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression. | Breast Cancer Res | 2024 | 38217030 | PubTator, text mining | PubMed |
| Role of SLC7A11/xCT in Ovarian Cancer. | Int J Mol Sci | 2024 | 38203758 | PubTator, text mining | PubMed |
| Roles of ubiquitin‑specific protease 13 in normal physiology and tumors (Review). | Oncol Lett | 2024 | 38192665 | PubTator, text mining | PubMed |
| Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma. | Heliyon | 2024 | 38187235 | PubTator, text mining | PubMed |
| LRRC75A-AS1 Drives the Epithelial-Mesenchymal Transition in Cervical Cancer by Binding IGF2BP1 and Inhibiting SYVN1-Mediated NLRP3 Ubiquitination. | Mol Cancer Res | 2024 | 38180377 | PubTator, text mining | PubMed |
| Cholesterol-induced HRD1 reduction accelerates vascular smooth muscle cell senescence via stimulation of endoplasmic reticulum stress-induced reactive oxygen species. | J Mol Cell Cardiol | 2024 | 38171043 | PubTator, text mining | PubMed |
| NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases. | Redox Biol | 2024 | 38150994 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84447/papers?page=8